Precision Biosciences (DTIL) Net Income Growth (1y) (2019 - 2026)
Precision Biosciences (DTIL) Net Income Growth (1y) (2019 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Income Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn | 6.48% |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn | -6.81% |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn | 96.45% |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn | 5.21% |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn | 151.28% |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn | 327.74% |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn | -228.03% |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn | 95.87% |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - | -12.04% |
| 10 | Precision Biosciences | 228.31 Mn | 140.77 Mn | - | 12.32% |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 15.49% |
| Mar 31, 2026 | 59.69% |
| Dec 31, 2025 | 154.45% |
| Sep 30, 2025 | 6.17% |
| Jun 30, 2025 | -242.42% |
| Mar 31, 2025 | -586.67% |
| Dec 31, 2024 | -736.22% |
| Sep 30, 2024 | -830.94% |
| Jun 30, 2024 | 275.73% |
| Mar 31, 2024 | 72.12% |
| Dec 31, 2023 | 68.49% |
| Sep 30, 2023 | 148.83% |
| Jun 30, 2023 | 75.30% |
| Mar 31, 2023 | 67.54% |
| Dec 31, 2022 | 70.50% |
| Sep 30, 2022 | 62.68% |
| Jun 30, 2022 | -283.49% |
| Mar 31, 2022 | -76.86% |
| Dec 31, 2021 | -26.44% |
| Sep 30, 2021 | 23.36% |